Molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 randomised, controlled, phase 3 trials

https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00037-7/fulltext?dgcid=hubspot_update_feature_updatealerts_lanhae&utm_campaign=update-lanhae&utm_medium=email&_hsenc=p2ANqtz--uNiZ1p-kiyeYDp9qhRb2GbdOomQHsLPMK6KiM5YW59VcMNAb1qutB2GPth0UmBqttt14gGoZCLeqn3MzhzTr_sqkkrQ&_hsmi=360940077&utm_content=360705662&utm_source=hs_email